BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25867763)

  • 1. Phenotypic diversity of patient-derived melanoma populations in stem cell medium.
    Sztiller-Sikorska M; Hartman ML; Talar B; Jakubowska J; Zalesna I; Czyz M
    Lab Invest; 2015 Jun; 95(6):672-83. PubMed ID: 25867763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
    Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
    PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.
    Sztiller-Sikorska M; Koprowska K; Jakubowska J; Zalesna I; Stasiak M; Duechler M; Czyz ME
    Melanoma Res; 2012 Jun; 22(3):215-24. PubMed ID: 22495670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
    Czyz M; Koprowska K; Sztiller-Sikorska M
    Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.
    Perego M; Tortoreto M; Tragni G; Mariani L; Deho P; Carbone A; Santinami M; Patuzzo R; Mina PD; Villa A; Pratesi G; Cossa G; Perego P; Daidone MG; Alison MR; Parmiani G; Rivoltini L; Castelli C
    J Invest Dermatol; 2010 Jul; 130(7):1877-86. PubMed ID: 20376064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.
    Marzagalli M; Moretti RM; Messi E; Marelli MM; Fontana F; Anastasia A; Bani MR; Beretta G; Limonta P
    Sci Rep; 2018 Jan; 8(1):587. PubMed ID: 29330434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
    Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
    Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
    Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA
    Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.
    Seftor EA; Seftor REB; Weldon D; Kirsammer GT; Margaryan NV; Gilgur A; Hendrix MJC
    Semin Oncol; 2014 Apr; 41(2):259-266. PubMed ID: 24787297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
    Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC
    Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
    Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
    PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
    Vachtenheim J; Novotná H
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.
    Ostyn P; El Machhour R; Begard S; Kotecki N; Vandomme J; Flamenco P; Segard P; Masselot B; Formstecher P; Touil Y; Polakowska R
    Cell Commun Signal; 2014 Sep; 12():52. PubMed ID: 25223735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.
    Rappa G; Fodstad O; Lorico A
    Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
    Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
    Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.